Prescription of Letrozole for Uterine Myoma
NCT06143631
This study is recruiting at 5 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
The PLUM Study is a randomized, double-blinded, 2-arm, parallel-group, placebo-controlled trial is designed to compare the efficacy of letrozole versus placebo on leiomyoma-related symptoms and quality of life as well as leiomyoma and uterine size.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Leiomyoma, Uterine
- Leiomyoma
- Fibroid
- Fibroid Uterus
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 21 to 53 years
- Sex
- Female
- Healthy volunteers
- Accepted
- Sponsor
- University of California, San Francisco
- Last updated on ClinicalTrials.gov
- October 6, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 2
- University of California, Los Angeles · Los Angeles, CA
- University of California, San Francisco · San Francisco, CA
Minnesota · 1
- Mayo Clinic · Rochester, MN
Mississippi · 1
- University of Mississippi Medical Center · Jackson, MS
North Carolina · 1
- Duke University · Durham, NC
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.